Search

everythinglearnresearchcommunity

for

Search:↓

Ent-kaurane-type diterpenoids from Isodonis Herba may promote hair growth by boosting cell proliferation.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Topical Ruxolitinib may safely treat severe hair loss.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Certain natural extracts can promote hair regrowth.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Women with acne have lower levels of a specific hormone marker than women without acne.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Solid Lipid Particle technology makes retinol more stable, effective, and gentle on the skin.

Tridax procumbens is a promising herb for developing safe, affordable plant-based medicines.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Turpentine ointment is effective and safe for treating folliculitis.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Topical IKKα inhibitors may help prevent CCS tumours.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Calancardin B may help reduce inflammation in immune cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Testosterone increases certain proteins in the uterus, reducing fluid volume.